Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of COVID-19 patients

a retrospective cohort study

Authors

Keywords:

COVID-19, Neutrophils, Lymphocytes, Intensive care units, Mortality, SARS-CoV-2, Survival

Abstract

BACKGROUND: Quick and accurate identification of critically ill patients ensures appropriate and correct use of medical resources. In situations that threaten public health, like pandemics, rapid and effective methods are needed for early disease detection among critically ill patients. OBJECTIVE: To determine the relationship between the neutrophil-to-lymphocyte ratio (NLR) of coronavirus disease-19 (COVID-19) patients upon admission to the emergency department (ED) and these patients’ prognosis. DESIGN AND SETTING: Retrospective cohort study among COVID-19 patients in the ED of a tertiary-level hospital. METHODS: Data on patients’ age, gender, vital signs, chronic diseases, laboratory tests and clinical outcomes were collected from electronic medical records. Receiver operating characteristic (ROC) curve analysis was performed. The area under the curve (AUC) was used to assess the accuracy of NLR for predicting in-hospital mortality risk and intensive care unit (ICU) requirement. The Youden J index (YJI) was used to determine optimal threshold values. RESULTS: 1,175 patients were included. Their median age was 63 years (IQR, 48-75). With an NLR cutoff value of 5.14, the sensitivity, specificity, PPV, AUC and YJI for ICU requirement were calculated as 77.87%, 74.08%, 92.4%, 0.811 and 0.5194, respectively. With the same cutoff value, the sensitivity, specificity, AUC and YJI for in-hospital mortality were 77.27%, 75.82%, 0.815 and 0.5309, respectively. In addition, advanced age, leukocytosis, anemia and lymphopenia were found to be associated with poor prognosis. CONCLUSION: The NLR, which is a widely available simple parameter, can provide rapid insights regarding early recognition of critical illness and prognosis among COVID-19 patients.

Downloads

Download data is not yet available.

Author Biographies

Erdal Yılmaz, Department of Emergency Medicine

MD. Specialist in Emergency Medicine, Department of Emergency Medicine, Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Istanbul, Turkey

Rohat Ak, Department of Emergency Medicine

MD. Specialist in Emergency Medicine, Department of Emergency Medicine, Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Istanbul, Turkey.

Fatih Doğanay, Department of Emergency Medicine

MD. Specialist in Emergency Medicine, Department of Emergency Medicine, Edremit Devlet Hastanesi, Balıkesir, Turkey.

References

Seyhan AU, Doganay F, Yilmaz E, Topal NP, Ak R. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19. J Coll Physicians Surg Pak. 2020;30(10):153-7. PMID: 33291194; https://doi.org/10.29271/jcpsp.2020.supp2.S153.

World Health Organization. Coronavirus disease 2019: situation report, 51. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?2. Accessed in 2021 (May 5).

Republic of Turkey Ministry of Health (2020). COVID-19 Information Page [online]. Available from: https://covid19.saglik.gov.tr/TR-66494/pandemi.html. Accessed in 2020 (May 14).

Abedi F, Rezaee R, Karimi G. Plausibility of therapeutic effects of Rho kinase inhibitors against severe acute respiratory syndrome coronavirus 2 (COVID-19). Pharmacol Res. 2020;156:104808. PMID: 32283223; https://doi.org/10.1016/j.phrs.2020.104808.

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. PMID: 32167524; https://doi.org/10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020;180(7):1031.

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. PMID: 32105632; https://doi.org/10.1016/S2213-2600(20)30079-5. Erratum in: Lancet Respir Med. 2020;8(4):e26. 7.

Covino M, De Matteis G, Burzo ML, et al. Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores. J Am Geriatr Soc. 2021;69(1):37-43. PMID: 33197278; https://doi.org/10.1111/jgs.16956.

Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533-41. PMID: 32181903; https://doi.org/10.1002/jmv.25767.

Mardani R, Ahmadi Vasmehjani A, Zali F, et al. Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020;8(1):e43. PMID: 32259132.

Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12. PMID: 32283162; https://doi. org/10.1016/j.jinf.2020.04.002.

Yan X, Li F, Wang X, et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol. 2020;92(11):2573-81. PMID: 32458459; https://doi.org/10.1002/jmv.26061.

Seyhan A U, Doğanay F, Yılmaz E, et al. The comparison of chest CT and RT-PCR during the diagnosis of COVID-19. Journal of Clinical Medicine of Kazakhstan. 2021;18(1):53-6. https://doi.org/10.23950/jcmk/9656.

Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47(4):458-72. PMID: 16161804; https://doi.org/10.1002/bimj.200410135.

Shapiro DE. The interpretation of diagnostic tests. Statistical methods in medical research. 1999;8(2):113-34. Available from: http://staff. pubhealth.ku.dk/~tag/Teaching/share/material/shapiro.pdf. Accessed in 2021 (May 5).

Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. PMID: 32109013; https://doi.org/10.1056/NEJMoa2002032.

Shang W, Dong J, Ren Y, et al. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188-92. PMID: 32436996; https://doi.org/10.1002/jmv.26031.

Asan A, Üstündağ Y, Koca N, et al. Do initial hematologic indices predict the severity of COVID-19 patients? Turk J Med Sci. 2021;51(1):39-44. PMID: 33003692; https://doi.org/10.3906/sag-2007-97.

Imran MM, Ahmad U, Usman U, et al. Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity. Int J Clin Pract. 2021;75(4):e13698. PMID: 32892477; https://doi.org/10.1111/ijcp.13698.

Vafadar Moradi E, Teimouri A, Rezaee R, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11-4. PMID: 33333477; https://doi.org/10.1016/j.ajem.2020.12.003.20.

Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. PMID: 32352535; https://doi.org/10.1093/cvr/cvaa106.

Song H, Kim HJ, Park KN, et al. Neutrophil to lymphocyte ratio is associated with in-hospital mortality in older adults admitted to the emergency department. Am J Emerg Med. 2021;40:133-7. PMID: 32008828; https://doi.org/10.1016/j.ajem.2020.01.044.

Zeng F, Li L, Zeng J, et al. Can we predict the severity of coronavirus disease 2019 with a routine blood test? Pol Arch Intern Med. 2020;130(5):400-6. PMID: 32356642; https://doi.org/10.20452/pamw.15331.

Lattanzi S, Cagnetti C, Rinaldi C, et al. Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage. J Neurol Sci. 2018;387:98-102. PMID: 29571881; https://doi.org/10.1016/j. jns.2018.01.038.

Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget. 2017;8(34):57489-94. PMID: 28915688; https://doi.org/10.18632/oncotarget.15423.

Świtońska M, Piekuś-Słomka N, Słomka A, et al. Neutrophil-to-Lymphocyte Ratio and Symptomatic Hemorrhagic Transformation in Ischemic Stroke Patients Undergoing Revascularization. Brain Sci. 2020;10(11):771. PMID: 33114150; https://doi.org/10.3390/brainsci10110771.

Bauer JM, Morley JE. Editorial: COVID-19 in older persons: the role of nutrition. Curr Opin Clin Nutr Metab Care. 2021;24(1):1-3. PMID: 33323712; https://doi.org/10.1097/MCO.0000000000000717.

Doğanay F, Elkonca F, Seyhan AU, et al. Shock index as a predictor of mortality among the Covid-19 patients. Am J Emerg Med. 2021;40:106-9. PMID: 33378732; https://doi.org/10.1016/j.ajem.2020.12.053.

Chhetri JK, Chan P, Arai H, et al. Prevention of COVID-19 in Older Adults: A Brief Guidance from the International Association for Gerontology and Geriatrics (IAGG) Asia/Oceania region. J Nutr Health Aging. 2020;24(5):471-2. PMID: 32346683; https://doi.org/10.1007/s12603-020-1359-7.

Downloads

Published

2022-06-01

How to Cite

1.
Yılmaz E, Ak R, Doğanay F. Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of COVID-19 patients: a retrospective cohort study. Sao Paulo Med J [Internet]. 2022 Jun. 1 [cited 2025 Mar. 14];140(1):1-6. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/673

Issue

Section

Original Article